Metformin Hydrochloride; Pioglitazone Hydrochloride Patent Expiration
Metformin Hydrochloride; Pioglitazone Hydrochloride is used for improving glycemic control in patients with type 2 diabetes already on a combination of pioglitazone and metformin or a thiazolidinedione (TZD) and metformin. It was first introduced by Takeda Pharmaceuticals Usa Inc
Metformin Hydrochloride; Pioglitazone Hydrochloride Patents
Given below is the list of patents protecting Metformin Hydrochloride; Pioglitazone Hydrochloride, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Actoplus Met | US5965584 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Actoplus Met | US6166042 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Actoplus Met | US6166043 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Actoplus Met | US6172090 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Actoplus Met | US9101660 | Solid preparation | Jan 22, 2027 | Takeda Pharms Usa |
| Actoplus Met | US9320714 | Tablet | Feb 03, 2029 | Takeda Pharms Usa |
| Actoplus Met Xr | US5965584 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Actoplus Met Xr | US6099859 | Controlled release oral tablet having a unitary core |
Mar 20, 2018
(Expired) | Takeda Pharms Usa |
| Actoplus Met Xr | US6166042 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Actoplus Met Xr | US6166043 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Actoplus Met Xr | US6172090 | Pharmaceutical composition |
Jun 19, 2016
(Expired) | Takeda Pharms Usa |
| Actoplus Met Xr | US6495162 | Controlled release oral tablet having a unitary core |
Mar 20, 2018
(Expired) | Takeda Pharms Usa |
| Actoplus Met Xr | US6790459 | Methods for treating diabetes via administration of controlled release metformin |
Mar 17, 2021
(Expired) | Takeda Pharms Usa |
| Actoplus Met Xr | US6866866 | Controlled release metformin compositions |
Mar 17, 2021
(Expired) | Takeda Pharms Usa |
| Actoplus Met Xr | US7785627 | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative | Jul 31, 2026 | Takeda Pharms Usa |
| Actoplus Met Xr | US7919116 | Controlled release metformin formulations |
Mar 20, 2018
(Expired) | Takeda Pharms Usa |
| Actoplus Met Xr | US7959946 | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative | Jul 31, 2026 | Takeda Pharms Usa |
| Actoplus Met Xr | US8470368 | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Sep 19, 2023
(Expired) | Takeda Pharms Usa |
| Actoplus Met Xr | US8475841 | Controlled release metformin formulations |
Mar 20, 2018
(Expired) | Takeda Pharms Usa |
| Actoplus Met Xr | US8668931 | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Sep 19, 2023
(Expired) | Takeda Pharms Usa |
| Actoplus Met Xr | US9060941 | Pharmaceutical formulation containing a biguanide and a thiazolidinedione derivative |
Sep 19, 2023
(Expired) | Takeda Pharms Usa |
Coming Soon
Patent Strength Analyzer
YesNo
Thank you for your response 🥳
Metformin Hydrochloride; Pioglitazone Hydrochloride Generics
Several generic applications have been filed for Metformin Hydrochloride; Pioglitazone Hydrochloride. The first generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride was by Mylan Pharmaceuticals Inc and was approved on Feb 25, 2011. And the latest generic version is by Macleods Pharmaceuticals Ltd and was approved on Nov 5, 2015.
Given below is the list of companies who have filed for Metformin Hydrochloride; Pioglitazone Hydrochloride generic.
1. MYLAN
Mylan Pharmaceuticals Inc has filed for 2 different strengths of generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Mylan.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 850MG; EQ 15MG BASE | tablet | Discontinued | ORAL | N/A | Feb 25, 2011 |
| 500MG; EQ 15MG BASE | tablet | Discontinued | ORAL | N/A | Feb 25, 2011 |
2. TEVA PHARMS USA
Teva Pharmaceuticals Usa has filed for 2 different strengths of generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Teva Pharms Usa.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 850MG; EQ 15MG BASE | tablet | Prescription | ORAL | AB | Mar 10, 2014 |
| 500MG; EQ 15MG BASE | tablet | Prescription | ORAL | AB | Mar 10, 2014 |
3. CHARTWELL RX
Chartwell Rx Sciences Llc has filed for 2 different strengths of generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Chartwell Rx.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG; EQ 15MG BASE | tablet | Discontinued | ORAL | N/A | Apr 16, 2013 |
| 850MG; EQ 15MG BASE | tablet | Discontinued | ORAL | N/A | Apr 16, 2013 |
4. AUROBINDO PHARMA LTD
Aurobindo Pharma Ltd has filed for 2 different strengths of generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Aurobindo Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG; EQ 15MG BASE | tablet | Prescription | ORAL | AB | Feb 13, 2013 |
| 850MG; EQ 15MG BASE | tablet | Prescription | ORAL | AB | Feb 13, 2013 |
5. TORRENT PHARMS LTD
Torrent Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Torrent Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 850MG; EQ 15MG BASE | tablet | Discontinued | ORAL | N/A | Feb 13, 2013 |
| 500MG; EQ 15MG BASE | tablet | Discontinued | ORAL | N/A | Feb 13, 2013 |
6. MACLEODS PHARMS LTD
Macleods Pharmaceuticals Ltd has filed for 2 different strengths of generic version for Metformin Hydrochloride; Pioglitazone Hydrochloride. All of these versions come by the name PIOGLITAZONE HYDROCHLORIDE AND METFORMIN HYDROCHLORIDE. Given below are the details of the strengths of this generic introduced by Macleods Pharms Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 500MG; EQ 15MG BASE | tablet | Prescription | ORAL | AB | Nov 5, 2015 |
| 850MG; EQ 15MG BASE | tablet | Prescription | ORAL | AB | Nov 5, 2015 |